indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
Published 1 year ago • 102 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:28
indirect comparison of momelotinib vs pacritinib safety and anemia outcomes in myelofibrosis
-
1:52
maic of momelotinib versus fedratinib safety in myelofibrosis
-
3:20
safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
1:22
real-world outcomes of patients with mf treated with fedratinib post-ruxolitinib discontinuation
-
3:05
ruxolitinib, pacritinib, fedratinib or momelotinib for thrombocytopenic patients with myelofibrosis
-
1:27
real-world use of fedratinib in patients with mf who have failed on ruxolitinib
-
2:44
myelofibrosis: jenson shares his experience
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
2:16
long-term safety of momelotinib for myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
3:46
an update on the summit trial: bezuclastinib in non-advanced systemic mastocytosis
-
5:25
indirect treatment comparison shows momelotinib has ‘favorable’ safety in myelofibrosis
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
2:04
phase i/ii study of a novel bet inhibitor, bms-986158, alone & with ruxolitinib or fedratinib in mf
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
2:53
long-term safety of momelotinib in myelofibrosis: pooled data from three phase iii randomized trials
-
7:40
dr. lucia masarova discusses indirect comparison of pacritinib and momelotinib in myelofibrosis
-
1:06
fedratinib: mpn-associated myelofibrosis
-
2:07
fedratinib for myelofibrosis